Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. (Q40272602)
Jump to navigation
Jump to search
scientific article published on June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. |
scientific article published on June 2006 |
Statements
Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells (English)
Jin T E Lim
Andrew K Joe
Masumi Suzui
Masahito Shimizu
I Bernard Weinstein